The nature of 3, 4-methylenedioxymethamphetamine (MDMA)-induced serotonergic dysfunction: evidence for and against the neurodegeneration hypothesis

DK Biezonski, JS Meyer - Current neuropharmacology, 2011 -


High doses of the recreational drug 3, 4-methylenedioxymethamphetamine (MDMA,“Ecstasy”) have been well-documented to reduce the expression of serotonergic markers in several forebrain regions of rats and nonhuman primates. Neuroimaging studies …

Last updated: Jul 27, 2020